New Assessment System in Measuring Symptom Distress in Cancer Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center
About this trial
This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to cancer and its treatment and how the symptoms impact quality of life.
Eligibility criteria
Qualifiers
NORMAL SAMPLES: Community dwelling adults 18 years of age or older
PATIENT SAMPLES: Inpatients and outpatients 18 years of age or older, being followed at UT MD Anderson
EXPERT PANEL PROFESSIONAL PARTICIPANTS: Physician or other healthcare provider with at least 5 years of experience caring for patients with the disease and/or treatment of interest, at least one publication in the last 5 years dealing with the disease and/or treatment of interest (physician only), ability to speak and read English, consent to participate
EXPERT PANEL FAMILY CAREGIVERS PARTICIPANTS: Identification as a family caregiver by patient enrolled as expert panel participant with the disease and/or treatment of interest, 18 years of age or older, ability to speak and read English, consent to participate
Disqualifiers
EXPERT PANEL PATIENT PARTICIPANTS: Patient with identified family caregiver participating on expert panel, willingness to receive packet for expert panel participation
Trial design
Treatments tested in this trial
- Interview
- Quality-of-Life Assessment
- Questionnaire Administration
Treatment groups
6,500 Participants
are divided into 1 treatment groupSponsors and collaborators
M.D. Anderson Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Bayer
Collaborator
Bristol-Myers Squibb
Collaborator
Eli Lilly and Company
Collaborator
Genentech, Inc.
Collaborator
Merck Sharp & Dohme LLC
Collaborator
National Institutes of Health (NIH)
Collaborator
Source ClinicalTrials.gov